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Conjugated linoleic acid (CLA) has been reported to improve muscle hypertrophy, steroidogenesis, physical activity, and endurance
capacity in mice, although the molecular mechanisms of its actions are not completely understood. The aim of the present study was to
identify whether CLA alters the expression of any of the peroxisome proliferator-activated receptor g coactivator 1a (PGC1a) isoforms,
and to evaluate the possible existence of fibre-type-specific hypertrophy in the gastrocnemius and plantaris muscles. Mice were randomly
assigned to one of four groups: placebo sedentary, CLA sedentary, placebo trained, or CLA trained. The CLA groups were gavaged with
35ml per day of Tonalin1 FFA 80 food supplement containing CLA throughout the 6-week experimental period, whereas the placebo
groups were gavagedwith 35ml sunflower oil each day. Each administered dose of CLA corresponded to approximately 0.7 g/kg or 0.5%, of
the dietary daily intake. Trained groups ran 5 days per week on a Rota-Rod for 6 weeks at increasing speeds and durations. Mice were
sacrificed by cervical dislocation and hind limb posterior muscle groups were dissected and used for histological and molecular analyses.
Endurance training stimulated mitochondrial biogenesis by PGC1a isoforms (tot, a1, a2, and a3) but CLA supplementation did not
stimulate PGC1a isoforms ormitochondrial biogenesis in trained or sedentary mice. In the plantarismuscle, CLA supplementation induced
a fibre-type-specific hypertrophy of type IIx muscle fibres, which was associated with increased capillary density and was different from the
fibre-type-specific hypertrophy induced by endurance exercise (of types I and IIb muscle fibres).
J. Cell. Physiol. 9999: 1–9, 2016. ß 2016 Wiley Periodicals, Inc.
A new class of food supplements known as “fat supplements”
have become popular among elite and recreational athletes
because they are marketed with claims to induce weight loss,
alter lipid profiles, improve performance, increase fat
metabolism, and increase testosterone synthesis and spare
glycogen stores during endurance exercise (Jeukendrup and
Aldred, 2004; Macaluso et al., 2012b). These supplements
include conjugated linoleic acid (CLA), long-chain
triacylglycerols, medium-chain triacylglycerols, and fish oil
(Macaluso et al., 2013). One of the most studied fat
supplements is CLA.
CLA is a group of positional and geometrical isomers of
conjugated dienoic octadecadienoate fatty acids produced
from linoleic acid by rumen bacteria (Kepler et al., 1966). CLA
contains two double bonds separated by a single bond in either
a cis or trans configuration. These double bonds can be located
in any position on the carbon chain, and are commonly
positioned between carbon molecules 8 and 13 (Dilzer and
Park, 2012). There are at least 28 known CLA isomers, but the
two most common are cis-9, trans-11 (c9:t11), and trans-10,
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cis-12 (t10:c12) (Dilzer and Park, 2012). CLA has been
described to possess a variety of beneficial effects such as anti-
cancer, -atherosclerosis, -osteoporotic, -oxidant, and -obesity
(Lim et al., 2005; Rahman et al., 2011; Kim et al., 2016).
CLA supplementation has the ability to reduce liver glycogen
consumption (Kim et al., 2010, 2012), resulting in decreased
lactate production (Kim et al., 2012) and increased fat utilization
(Mizunoya et al., 2005; Kim et al., 2010, 2012), and therefore
elongating time to exhaustion during running (Kim et al., 2010,
2012) and swimming (Mizunoya et al., 2005) in mice. CLA may
regulate skeletal muscle metabolism by a newly identified
molecular pathway, improving oxidative phosphorylation and
antioxidant capacity in rodentmodels (Choi et al., 2007; Rahman
et al., 2009). Recently, Kim and Park (2015) have reported that
CLA treatment significantly upregulated peroxisome
proliferator-activated receptor g coactivator 1a (PGC1a) in a
murine skeletal muscle cell line. In contrast, Parra et al. (2012)
showed that CLA treatment did not affect PGC1a gene
expression in sedentary mice supplemented with standard-fat
(over 37 days) and high-fat diet (over 65 days).
PGC1a is a transcriptional coactivator that controls the
expression of genes involved in the regulation of fatty acid
oxidation, glucosemetabolism, and antioxidants (St-Pierre et al.,
2003; Rodgers et al., 2005; Gerhart-Hines et al., 2007; Garcia-
Carrizo et al., 2016). It is considered the “master regulator of
mitochondria” (Ventura-Clapier et al., 2008), as it regulates
mitochondrial transcription factors (Scarpulla, 2002) such as the
nuclear respiratory factor (NRF) family. It has been reported
that PGC1a may induce many of the changes associated with
endurance training, including mitochondrial biogenesis, fibre-
type switching, stimulation of fatty acid oxidation, angiogenesis,
and resistance to muscle atrophy (Ruas et al., 2012). Recent
studies have found that the PGC1a gene containsmore thanone
promoter and transcribesmultiple isoforms (Zhang et al., 2009).
Ruas et al. (2012) suggested that PGC1 a4 is preferentially
induced during resistance exercise in mice. Similarly, Lundberg
et al. (2014) and Ydfors et al. (2013) have also shown that
endurance exercise affects PGC1 a4 expression in human
skeletal muscle. Recently, we observed that endurance exercise
increases the expression of PGC1 a1, a2, and a3 isoforms in
murine soleus muscle (Barone et al., 2016a).
We hypothesized that CLA supplementation, whether
accompanied by endurance training or not, may stimulate
mitochondrial biogenesis through activation of the PGC1a
isoforms. The aim of the present study was to identify if CLA
alters the expression of any of the PGC1a isoforms, and to
evaluate the presence of a possible fibre-type-specific
hypertrophy in the gastrocnemius and plantaris muscles.
Materials and Methods
Animals and animal care
Animal experiments were performed at the animal experimental
facilities of the Human Physiology Laboratory (University of
Palermo, Department of Experimental Biomedicine and Clinical
Neuroscience, authorized by the Ministero della Sanita of Rome,
Italy). The experimental procedure received prior approval from
the Committee on the Ethics of Animal Experiments of the
University of Palermo (Italy), and adheres to the Guide for the
Care and Use of Laboratory Animals of the National Institute
of Health (NIH). Thirty-two young (7 weeks old) male mice
(BALB/cAnNHsd) were obtained from Harlan laboratories S.r.l.
(Italy). Mice weremaintained on a constant 12:12-h light-dark cycle
with free access to food and water.
CLA-administration and training protocol
Mice were randomly distributed into 4 groups of 8 mice each:
placebo sedentary (PLA-SED); CLA sedentary (CLA-SED); placebo
trained (PLA-TR); CLA trained (CLA-TR). The CLA groups
(CLA-SED; CLA-TR) were gavaged with 35ml•d  1 of Tonalin1
FFA 80 (Cognis Nutrition and Health, Germany) food supplement
containing CLA throughout the 6-week experimental period,
whereas the placebo groups (PLA-SED; PLA-TR) were gavaged
with 35ml•d  1 of sunflower oil. Each administered dose of CLA
corresponded to approximately 0.7 g/kg, or 0.5%, of the dietary
daily intake. Tonalin1 FFA 80 contained 84% CLA (40% c9:t11,
40% t10:c12, and 4% other CLA isomers), 12% oleic acid, 3%
stearic acid, 0.5% palmitic acid, and 0.5% linoleic acid. This
supplementation procedure has been previously by our research
group (Barone et al., 2013).
Trained groups (PLA-TR; CLA-TR) ran 5 days/week for 6 weeks
at progressively increasing durations and intensities on a
motorized Rota-Rod (Ugo Basile, Biological Research Apparatus,
Italy). The training protocol and procedures have been described
previously by our research group (Bellafiore et al., 2007a,b;
Chimenti et al., 2007; Di Felice et al., 2007). Sedentary mice
(PLA-SED; CLA-SED) did not perform any controlled physical
activity. Forty-eight hours after the completion of the final exercise
session, all mice were sacrificed by cervical dislocation and hind
limb posterior muscle groups (the gastrocnemius and plantaris
muscles) were dissected. Muscles from the right hind limb were
frozen in liquid nitrogen and stored at   80°C, whereas the
muscles from the left hind limb were fixed (acetone, methanol, and
water—2:2:1; for 12 h) and embedded in paraffin (Rappa et al.,
2014; Barone et al., 2016b).
Immunohistochemistry
For immunohistochemical analysis, serial cross sections (5mm) of
paraffin-embedded muscles were mounted on a slide and
incubated in an “antigen unmasking solution” (10mM tri-sodium
citrate, 0.05% Tween-20) for 10min at 75°C. Following this, the
MACH1 kit (M1u539g, Biocare, CA) was used according to the
manufacturer’s instructions. The immunohistochemistry protocol
and procedures have been described previously by our research
group (Macaluso et al., 2012a; Pomara et al., 2016). The primary
antibodies used were anti-myosin heavy chain-I (MHC-I; A4951,
Hybridoma Bank, IA) and anti-myosin heavy chain-II (MHC-II;
A474, Hybridoma Bank). Immunohistochemical images were
captured using a Leica DM5000 upright microscope (Leica
Microsystems, Heidelberg, Germany). Cross-sectional area (CSA)
of types I and II muscle fibres from the plantaris and gastrocnemius
muscles weremeasured using ImageJ 1.41 software. Analyses were
performed using five fields per section, five sections per mouse
(40mmbetween sections), and eight mice per group. An average of
287 fibres were analyzed for each mouse.
Immunofluorescence and confocal analysis
For immunofluorescence, deparaffinized sections were
incubated in the “antigen unmasking solution” (10mM tri-sodium
citrate, 0.05% Tween-20) for 10min at 75°C and treated with a
blocking solution (3% BSA in PBS) for 30min. Next, the primary
antibody (anti-Isolectin GS-IB4, Alexa Fluor 488 conjugate
I21411, Life Technologies, Monza, Italy or anti-laminin, rabbit
polyclonal AB2034, Millipore, Temecula, CA) diluted 1:50, was
applied, and the sections were incubated in a humidified chamber
overnight at 4°C. The sections were then incubated for 1 h
at 23°C with a conjugated secondary antibody (anti-rabbit
IgG–FITC antibody produced in goat, F0382, Sigma–Aldrich,
St. Louis, MO). Nuclei were stained with Hoechst Stain Solution
(1:1000, Hoechst 33258, Sigma–Aldrich). The slides were
treated with PermaFluor Mountant (Thermo Fisher Scientific,
Inc., Waltham, MA) and cover slipped. The images were
captured using a Leica Confocal Microscope TCS SP8 (Leica
Microsystems) and analyses were performed using four fields per
section, five sections per mouse, and six mice per group.
JOURNAL OF CELLULAR PHYSIOLOGY
2 B A R O N E E T A L.
Immunoblotting
Frozen skeletal muscles (approximately 250mg each, inclusive of
both the gastrocnemius and the plantaris muscles) were
homogenized by hand (using mortar and pestle) in an ice-bath in
lysis buffer. The protocol and procedures for immunoblotting and
sample preparation have been described previously by our
research group (Pomara et al., 2016). Primary antibodies used
were anti-MnSOD (diluted 1:1000, rabbit polyclonal antibody
ADI-SOD-110, Enzo Life Sciences Inc., Farmingdale, NY), anti-
phospho-AMPKa (diluted, 1:1000, rabbit polyclonal antibody
07-681SP, Millipore), anti-AMPKa1 (diluted 1:1000, rabbit
polyclonal antibody 07-350SP, Millipore), anti-PGC1a (diluted
1:1000, mouse monoclonal antibody ST1202, Calbiochem Inc., San
Diego, CA), anti-TFAM (diluted 1:1000, rabbit polyclonal antibody
DR1071, Calbiochem Inc.), anti-Hsp60 (diluted 1:3000, mouse
monoclonal antibody ab13532, Abcam, UK), and anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; diluted
1:3000, rabbit polyclonal antibody ADI905784, Enzo Life Sciences).
The detection of immunopositive bands was performed using ECL
Western Blotting Detection Reagent (Amersham Biosciences,
Valley Stream, NY) according to the manufacturer’s instructions.
The immunoblotting bands were analysed using ImageJ software
version 1.41 (NIH; http://rsb.info.nih.gov/ij). GAPDH immuno-
blotting band intensity was examined as the loading control. Each
experiment was performed at least five times.
Total RNA and DNA isolation
Total RNA and DNA (genomic and mtDNA) were extracted using
Tri-reagent (Sigma–Aldrich) according to the manufacturer’s
instructions (Campanella et al., 2015) from the frozen muscles of 8
mice for each group. Sample RNA and DNA concentrations were
quantified by spectrophotometric analysis using the NanoDrop
2000 UV-Vis Spectrophotometer (Thermo Scientific, IL).
Quantitative real-time PCR (qRT-PCR)
Reverse transcriptionwas performed using 300 ng of the extracted
RNA and the ImProm-II Reverse Transcriptase Kit (Promega,
Madison, WI) according to the manufacturer’s instructions.
Complementary deoxyribonucleic acid (cDNA, 20 ng) was
amplified by qRT-PCR, which was performed using GoTaq qPCR
Master Mix (A6001, Promega) and a Rotor-geneTM 6000 Real-
Time PCR Machine (Qiagen GmbH, Hilden, Germany) using
primers indicated in Table 1. Changes in transcription level were
calculated using the 2–DDCT method and normalized to
transcription levels of GAPDH (Di Felice et al., 2015). PCR
fragments purified using the Nucleospin PCR and Gel Clean-up Kit
(Macherey-Nagel GmbH &Co. KG, Germany) were sequenced by
Eurofins Sequencing Service (Germany). Sequences were then
analyzed with the BLASTn Web Tool on the NIH website (http://
www.ncbi.nlm.nih.gov/BLAST/). All PCR-amplified fragments
corresponded to the desired target.
Relative mitochondrial copy number method
qRT-PCR analysis was performed using GoTaq qPCR Master Mix
(A6001, Promega) using three optimized PCRprimer pairs targeting
two mitochondrial (mt-12S andmt-Cyt_b) and one nuclear (Becn1)
gene (Table I). The protocol, procedures, and mathematical
formulae for calculating mitochondrial copy number have been
described previously by our research group (Barone et al., 2016a).
The amplification primers were validated for matching amplification
efficiency and the absence of any amplification of mitochondrial
pseudogenes by sequencing of PCR products and comparing
amplicon sequences with BLASTn database.
Statistical analysis
Normality of the data and homogeneity of the variance were
verified. Two-way ANOVA for single measurements followed by
Bonferroni post-hoc test was used for data analysis. All statistical
analyses were performed using the program GraphPad PrismTM
4.0 (GraphPad Software Inc., San Diego, CA). All data are
presented as the mean SD, and the level of statistical significance
was set at P< 0.05.
Results
Effects of endurance training and CLA supplementation
on the CSAs of posterior hind limb muscle fibres
To evaluate the hypertrophic effects of endurance exercise and
CLA supplementation on the hind limb posterior muscle group
(gastrocnemius and plantarismuscles), CSA was evaluated in the
different muscle fibre types. Morphometric analysis showed
that endurance training increased the CSA of type IIb fibres in
the plantaris and gastrocnemius muscles and of type I fibres
exclusively in the gastrocnemius (P< 0.0001). CLA
supplementation induced a main effect on the CSA of type IIa
and x fibres in the plantaris muscle (P< 0.05), although the
significant difference for IIx muscle fibres was only detected
between the PLA-TR and CLA-TR groups (P< 0.01). Analysis
on type I fibres of the plantaris muscle was not performed
because of their relative paucity (three to four fibres for each
muscle). CLA supplementation did not induce any effect in the
gastrocnemius muscle. Morphometric analysis of the plantaris
and gastrocnemius muscles are shown in Figure 1.
CLA supplementation induced the increase of isolectin
levels in plantaris muscle
To assess the effects of endurance exercise and CLA
supplementation on capillary density, immunofluorescence
staining using a specific antibody against isolectin GS-IB4 was
performed on the hind limb gastrocnemius and plantarismuscles
(Fig. 2A). Isolectin immunoreactivity levels were analyzed by
confocal microscopy using the Leica Application Suite
Advanced Fluorescences software. Two-way ANOVA analysis
TABLE 1. Forward and reverse primers used for qRT-PCR
Primer Forward Reverse
PGC1 tot 50-TGATGTGAATGACTTGGATACAGACA-30 50-GCTCATTGTTGTACTGGTTGGATATG-30
PGC1 a1 50-GGACATGTGCAGCCAAGACTCT-30 50-CACTTCAATCCACCCAGAAAGCT-30
PGC1 a2 50-CCACCAGAATGAGTGACATGGA-30 50-GTTCAGCAAGATCTGGGCAAA-30
PGC1 a3 50-AAGTGAGTAACCGGAGGCATTC-30 50-TTCAGGAAGATCTGGGCAAAGA-30
PGC1 a4 50-TCACACCAAACCCACAGAAA-30 50-CAGTGTGTGTATGAGGGTTGG-30
HSP60 50-ACGATCTATTGCCAAGGAGG-30 50-TCAGGGGTTGTCACAGGTTT-30
GADPH 50-CAAGGACACTGAGCAAGAGA-3’ 5’-GCCCCTCCTGTTATTATGGG-3’
BECN1 50-CGAGTGCCTTCATCCAAAAC-30 50-GTCCTGGCACCTCTCTAATG-30
mt-Cytb 50-TAGCAATCGTTCACCTCCTC-30 50-TGTAGTTGTCTGGGTCTCCT-30
mt_12s 50-GATAAACCCCGCTCTACCTC-30 50-CATTGGCTACACCTTGACCT-30
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Fig. 1. Histological evaluation of hind limb posterior muscle group (gastrocnemius and plantaris muscles). (A) Explanatory
immunohistochemistry for MHC-I and MHC-IIa/x in serial cross-sections of gastrocnemius muscle. Type IIb fibres are negative to
antibodies anti-MHC-I and anti-MHC-IIa/x. Skeletal muscle fibres cross sectional area (CSA) of plantaris (B) and gastrocnemius
(C) muscles of trained (TR) and sedentary (SED) mice supplemented with conjugated linoleic acid (CLA) or placebo (PLA). Data
are presented as the meanSD. #Significantly different (P< 0.05), (P< 0.01).
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did not show any significant difference between the groups
whereas isolectin immunoreactivity was significantly higher in
response to CLA supplementation (P< 0.001) in the plantaris
muscle (Fig. 2B).
Endurance training induced the increase of p-AMPKa and
PGC1a protein levels
MnSOD, p-AMPKa, AMPKa1, PGC1a, TFAM, and Hsp60
protein analyses were performed on the hind limb posterior
muscle group (gastrocnemius and plantaris muscles) using
western blot analysis (Fig. 3). p-AMPKa and PGC1a protein
levels were significantly higher in both trained groups (PLA-TR
and CLA-TR) compared to the sedentary groups (PLA-SED
and CLA-SED; P< 0.01). As shown in Figure 3, p-AMPKa and
PGC1a protein levels significantly increased as a consequence
of endurance training (P< 0.0001) and not as an effect of CLA
supplementation. Mn SOD, AMPKa1, TFAM, and Hsp60
protein levels were not affected by training and/or
supplementation.
CLA supplementation did not induce variation in PGC1a
isoform gene levels
Quantitative RT-PCR analysis showed a significant increase
in total PGC1 a1, a2, and a3 isoforms (P< 0.05; Fig. 4A) in
response to endurance training in the hind limb posterior
muscle group (gastrocnemius and plantaris muscles). CLA
supplementation did not induce any significant changes on
PGC1a isoform gene expression levels. Moreover, PGC1
isoform a4 gene expression was not detected in any muscle
samples.
Endurance training induced the increase ofmitochondrial
content in gastrocnemius and plantaris muscles
As shown in Figure 4B, mtDNA copy number in hind limb
posterior muscle groups (gastrocnemius and plantaris muscles)
significantly increased in response to endurance training
(P< 0.01), but not in response to CLA supplementation.
Discussion
The results obtained in our study suggested that endurance
training may stimulate mitochondrial biogenesis in mice and
activate three PGC1 isoforms (a1, a2, and a3) whereas CLA
supplementation, whether associated or not with endurance
exercise, did not stimulate further mitochondrial biogenesis.
The protein and gene expression levels of PGC1a were not
directly affected by CLA supplementation. Interestingly, our
endurance training protocol induced hypertrophy of types I
and IIb muscle fibres in plantaris and gastrocnemius muscles, in
Fig. 2. Confocal microscopy analysis for isolectin GS-IB4 in plantaris and gastrocnemius muscles. A, immunofluorescence for isolectin GS-IB4
(green) and laminin (red) of cross-sections of plantaris and gastrocnemius muscles of trained (TR) and sedentary (SED) mice supplemented
with conjugated linoleic acid (CLA) or placebo (PLA). Bar 25mm. B, the staining intensity for isolectin GS-IB4 (bars) was expressed as the
mean pixel intensity (PI) normalized to the CSA (cross-sectional area) using the software Leica Application Suite Advanced Fluorescences
software. Open bar, groups of the study. Data are presented as the meanSD.
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sharp contrast to CLA supplementation, which only induced a
specific hypertrophy of type IIx muscle fibres in the plantaris
muscle.
The current literature indicates that CLA supplementation
affects skeletal muscle metabolism (Kim et al., 2016). Studies
conducted in animals and in humans showed controversial
results on the effect of CLA supplementation on lean body
mass due to different factors, such as subject characteristics
and form of supplementation, dosage, duration period, study
design, treatment type, etc. A comprehensive and updated
review has been recently published to provide a systematic
assessment of skeletal musclemetabolic adaptation in response
to CLA supplementation in humans and in rodents (Kim et al.,
2016). Our research group has previously shown that 6 weeks
of CLA supplementation associated with progressive
endurance training, increased lean body mass, and muscle
hypertrophy (Di Felice et al., 2007; Barone et al., 2013). In this
study, our endurance training protocol increased the CSA of
types I and IIb muscle fibres in the gastrocnemius and type IIx
fibres in the plantaris muscle. It is known that endurance
exercise, as it mainly stimulates slow oxidative fibres (i.e., type I
fibres), induces muscle hypertrophy of this fibre (Schiaffino and
Reggiani, 2011). Type IIb fibres, fast-glycolytic fibres, are more
susceptible than other fibre types to hypertrophic and atrophic
stimuli induced by training or muscle wasting, respectively
(Schiaffino and Reggiani, 2011). Moreover, we have shown that
the hypertrophy present in trained mice supplemented with
CLAwas fibre-type andmuscle-specific. In fact, the CSA of type
IIx muscle fibres of the plantaris muscle was significantly higher
in trained mice supplemented with CLA than in trained mice
supplemented with placebo, but this difference was not
detected in the gastrocnemiusmuscle. The difference in muscle-
specific hypertrophy effects may be due to the different
biomechanical functions of these two muscles during
quadruped plantigrade locomotion, as suggested by Schiaffino
and Reggiani (2011). After CLA supplementation, hypertrophy
of the plantaris muscle was accompanied by an increase of
capillary density, possibly due to the higher oxygen demand.
However, we did not observe the same effects in the
gastrocnemiusmuscle because it is rich in type IIb muscle fibres,
which are less involved in the types of physical activity induced
by this exercise protocol. To the best of our knowledge, there
is no data regarding CLA supplementation and capillary density
in skeletal muscles.
It has been recently reported that CLA (c9:t11 and/or t10:
c12 isomers), in a murine skeletal muscle cell line, engaged the
Fig. 3. Protein levels of MnSOD, p-AMPKa, AMPKa1, PGC1a, TFAM, and Hsp60 of hind limb posterior muscle group (gastrocnemius and
plantaris muscles). Representative western blots (A) and relative expression levels (B) of MnSOD, p-AMPKa, AMPKa1, PGC1a, TFAM, and
Hsp60 in hind limb posterior muscle group of trained (TR) and sedentary (SED) mice supplemented with conjugated linoleic acid (CLA) or
placebo (PLA). Data are presented as the meanSD. Significantly different (P< 0.001) #(P< 0.01).
JOURNAL OF CELLULAR PHYSIOLOGY
6 B A R O N E E T A L.
Fig. 4. qRT-PCR analysis of PGC1a isoforms and mitochondrial DNA copy number. (A) PGC1a isoforms (PGC1a total (atot), isoform 1
[a1], 2 [a2], 3 [a3]) gene expression normalized for the reference genes and (B) copy number of mitochondrial genes in hind limb posterior
muscle group of trained (TR) and sedentary (SED) mice supplemented with conjugated linoleic acid (CLA) or placebo (PLA). Data are
presented as the meanSD. Significantly different (P< 0.01).
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mitochondrial biogenesis process through modulation of the
PGC1a-TFAM cascade. On the other hand, Parra et al. (2012)
reported that a commercial CLA mixture did not affected
PGC1a gene expression in the gastrocnemius muscle of mice
fed with standard or high-fat diets. Moreover, CLA treatment
did not affect PGC1a activity despite increasing the
mitochondrial content in human skeletal muscle cells (Vaughan
et al., 2012). To the best of our knowledge, no study has been
conducted to investigate the effect of CLA supplementation on
mitochondrial biogenesis in the skeletal muscle of a trained
model.
As expected, exercise training increased the protein
expressions of PGC1a, p-AMPKa, and the gene expression
levels of PGC1 a1, a2, and a3 isoforms relative to sedentary
controls. These results confirmed our previous finding: that a
progressive endurance exercise protocol of 6 weeks was able
to induce mitochondrial biogenesis, likely via activation of the
transcription factor PGC1a; even though we did not observe
an increase in the expression of TFAM, MnSOD, or AMPKa1,
which are key factors of the mitochondrial biogenesis pathway
(Powers et al., 2011; Barone et al., 2016a). CLA
supplementation failed to induce changes in the levels of these
factors in both sedentary and trained mice.
Our previous data demonstrated that elevated PGC1a
levels were paralleled by increased levels of Hsp60 both in vitro
and in vivo. In particular, Hsp60 protein expression was fibre-
specific (type I, IIa) and increased after 45 days of endurance
training in the soleusmuscle (Barone et al., 2016a). This protein
is classically described as a mitochondrial protein involved in
assisting the correct folding of other mitochondrial proteins
(Kon, 1985). The chaperonin may be induced by different types
of stress, as well as physical exercise (Morton et al., 2009;
Cappello et al., 2014). In the present study, Hsp60 protein
levels were not different between the experimental groups.
These results are in disagreement with our previous data,
probably because different muscle types were investigated.We
herein carried out a study on the hind limb posterior muscle
group (gastrocnemius and plantarismuscles), which is rich in type
IIb muscle fibres expressing low levels of Hsp60 (Barone et al.,
2016a).
Our analysis of muscle mitochondrial content showed that
only endurance exercise and not CLA supplementation
induced an increase in mtDNA. We reported that short term
CLA supplementation (45 days) in trained mice had the ability
to increase endurance exercise capacity by improving the
distance run prior to exhaustion onset (Barone et al., 2013).
Therefore, this previously observed improvement in
endurance exercise capacity was not due to mitochondrial
biogenesis. The levels of the PGC1a isoforms transcribed by
the activation of the proximal or the alternative promoter, or
as a result of an alternative splicing of exon 1, were also
investigated to further study the relationship between CLA
supplementation and endurance exercise capacity. The results
obtained indicated that CLA supplementation, either alone or
associated with endurance training, did not induce any changes
in the expression of the PGC1a protein or its isoforms (a1,a2,
and a3). Primary aerobic adaptations induced by endurance
training, other than increased mitochondrial number and size
(Holloszy and Coyle, 1984), also include increased skeletal
muscle blood flow (Krustrup et al., 2004), increased
mitochondrial enzyme activity for oxidized fatty acids
(Holloszy and Coyle, 1984), delayed onset of anaerobic
metabolism (Hurley et al., 1984), and reduced accumulations of
catabolic products (Hurley et al., 1984). Therefore, it is not
possible to exclude the possibility of other adaptations induced
by CLA supplementation on skeletal muscle.
In conclusion, the data obtained showed that short-term
CLA supplementation, whether associated with endurance
exercise or not, did not stimulate mitochondrial biogenesis by
PGC1a isoform activation, but did induce hypertrophy in type
IIx fibres in the plantaris muscle after endurance exercise. We
therefore believe that further studies using a different time
course of CLA supplementation are required to better
understand the effects of this food supplement on skeletal
muscle.
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